With additional research effort currently focused on SARS-CoV-2/COVID-19, and the usual work of many scientists affected by issues such as lab and university closures, this newsletter brings you COVID-related news and content from the FEBS Press journals and the FEBS Network platform. For interest beyond the pandemic, it also highlights thematic collections from the journals and recent Network posts on other topics.
FEBS Press: COVID-19 update
Publishing your papers
Our journals – The FEBS Journal, FEBS Letters, FEBS Open Bio and Molecular Oncology – have been able to continue offering efficient services to authors. They understand that many researchers are displaced from their labs, and so are happy to give revision extensions when requested. COVID-related submissions are being fast-tracked through the review and publication process, and usually receive a decision within 1–2 weeks.
COVID-19 articles
- Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic: Q&A with virologist Professor Urs Greber, D. Ruffell, FEBS Letters (2020) doi:10.1002/1873-3468.13784
- A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2, C. L. Atzrodt, I. Maknojia, R. D. P. McCarthy, T. M. Oldfield, J. Po, K. T. L. Ta, H. E. Stepp, T. P. Clements, The FEBS Journal (2020) doi:10.1111/febs.15375
- Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?, J. L. Olds, N. Kabbani, The FEBS Journal (2020) doi:10.1111/febs.15303
- SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection, K. H. Ebrahimi, FEBS Letters (2020) doi: 10.1002/1873-3468.13845
- Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank, A. Wlodawer, Z. Dauter, I. Shabalin, M. Gilski, D. Brzezinski, M. Kowiell, B. Rupp, M.Jaskolski, The FEBS Journal (2020) doi:10.1111/febs.15366
- Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs, A.Hijikata, C. Shionyo-Mitsuyama, S. Nakae, M. Shionyu, M. Ota, S. Kanaya, T. Shirai, FEBS Letters (2020) doi:10.1002/1873-3468.13806
- Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing, O. O. Glebov, The FEBS Journal (2020) doi:10.1002/2211-5463.12875
- Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease, M. Tsuji, FEBS Open Bio (2020) doi:10.1002/2211-5463.12875
Latest FEBS Press Special Issues
Enzyme Promiscuity and Evolution, a Special Issue from The FEBS Journal, presents ten expert reviews that delve into the intricacies of this topic, particularly in the context of cellular metabolism.
Adenoviruses: Biology, Disease and Therapy, a FEBS Letters Special Issue edited by Urs Greber, covers all aspects of adenoviral biology, including structure, function, immune evasion, therapeutic approaches and evolution.
Cell Cycle Control, a FEBS Letters Special Issue edited by Jörg Mansfeld and Alexis Barr, focuses on the tightly controlled mechanisms that underlie progression through the cell cycle, and how dysregulation of these processes can lead to disease.
Don’t miss Part 2 of each of the FEBS Letters Special Issues, coming soon.
FEBS Network: COVID-19 update
COVID-related posts on the FEBS Network span undergraduate teaching resources, perspectives on researcher life at this unusual time, and comment on issues for debate. Contributions are being gathered in a Coronavirus insights room. Here’s a flavour:
- Coronavirus RT-qPCR testing tutorial, Gus Cameron
- Rapid tests for coronavirus: how do they work?, Angel Herráez
- Lessons from lockdown: moving meetings online, Pleasantine Mill
- Lab management during the coronavirus pandemic – Part II: how to restart a research group after quarantine, Magdalena Koziol
- Vaccine research bioethics: does the COVID-19 pandemic argue for special considerations for testing?, FEBS Communications
- COVID-19 – European unity & support for science more important than ever, Marieke Meijer
Missing in-person discussions on your research subject? A ‘room’ for your topic on the FEBS Network could help; find out more about applying to set one up from the post Build an online community for your research area
Discover more on the FEBS Network: May 2020 highlights
You are invited to register on the FEBS Network to access all its features, including presenting your profile, commenting and setting up alerts.
